Global Automated Breast Ultrasound Systems Market Is Likely To Grow At A CAGR Value Of Around 15.80% By 2028

The global Automated Breast Ultrasound Systems market was worth around USD 792.70 billion in 2021 and is estimated to grow to about USD 1911.43 billion by 2028, with a compound annual growth rate (CAGR) of approximately 15.80 percent over the forecast period. The report analyzes the digital remittance market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the digital remittance market.

Breast cancer is one of the most common diseases in the world, and it is also the most common cancer in women, making it a serious health concern. As a result, healthcare providers place a high value on early detection to reduce morbidity and death and enhance survival rates. Mammography and ultrasound are well-known screening and early detection methods for breast cancer. The breast ultrasound system has demonstrated promising results in the identification of tumours in women with thick breasts when used in conjunction with mammography. On the other hand, both mammography and traditional breast ultrasonography have technical limitations, paving the way for the development of ABUS.

The automated breast ultrasound (ABUS) system is a new technological innovation in ultrasound imaging that was designed to eliminate the need for an operator. The ABUS system produces high-resolution three-dimensional imaging in a repeatable manner. ABUS is noted for its ease of use, accuracy, and efficiency. ABUS has been demonstrated to have higher sensitivity, cancer detection rates, diagnostic accuracy rates, and picture quality in various studies and research. Recent advancements in ABUS systems have made it feasible to recreate superior quality images in a short amount of time thanks to the use of high-frequency transducers.

Rising breast cancer prevalence and occurrences, a growing radiology industry, and more patient awareness of the link between breast density and breast cancer are all driving demand for automated breast ultrasound systems. Furthermore, market demand should be boosted by technological developments in the development of superior imaging techniques, as well as greater government financing for breast cancer awareness. Furthermore, the benefits of automated breast ultrasound systems such as 3D imaging, high quality imaging, coronal view, and speedy findings with guarantee of improved diagnostic outcomes are propelling the market for automated breast ultrasound systems forward. 

The market for Automated Breast Ultrasound Systems is segmented by product, application, end user, and geography. The market is divided into two categories based on product: Automated Breast Ultrasound System and Automated Breast Volume Scanner. The automated breast ultrasound system market is predicted to expand at a quicker rate by 2028. Technological advancements in breast cancer detection equipment are one of the key drivers raising the worldwide automated breast ultrasonography system. Companies are developing a number of new technologies to improve cancer screening in patients with thick breasts, increasing the efficiency of breast cancer detection. Traditional systems are likely to be improved by ABUS advancements. As a result of such technological developments, customer adoption of enhanced cancer imaging will rise, driving industry growth.

The Automated Breast Ultrasound Systems market is divided into three types of end users: hospitals, diagnostic centres, and ambulatory surgical centres. In the anticipated time, the diagnostic imaging centres segment will have a bigger share. The increase of diagnostic centre capacity for early detection and identification of malignant cells in the body will hasten segmental growth. As expert diagnosis tools and technology become more broadly available, breast cancer detection technologies will be implemented at a faster rate. 

North America leads the global Automated Breast Ultrasound Systems market according to the American Society of Cancer, women will be diagnosed with 281,550 new cases of breast cancer in 2021, with 43,600 women dying from the disease. As breast cancer becomes more widespread, the demand for better breast imaging technology and therapies will rise. Increased government programmes to raise awareness and educate women about breast cancer and the importance of screening will boost the ABUS market in the United States. The National Breast Cancer Awareness (NBCA) month, the National Breast Cancer Foundation's awareness initiatives, and the Susan Komen Foundation's are all part of the American Society of Cancer's National Breast Cancer Awareness (NBCA) month. The demand for automated breast ultrasonography devices for breast cancer screening in dense breast tissue will increase as a result of these factors

Key players functioning in the global Automated Breast Ultrasound Systems market include Canon Medical System, GE Healthcare,Hitachi Ltd., koninklijke Philips N.V, Metritrack Inc., Nova Medical Imaging Technology Co. Ltd, Qview Medical Inc., SonoCine Inc. and SuperSonic Imgine

Recent developments:

• In November 2021, QView Medical, a well-known supplier of cutting-edge medical technology, has teamed with GE Healthcare, a major breast cancer detection company based in the United States. As a result of this collaboration, the former will be able to launch its QVCAD software on the latter's Invenia ABUS 2.0 platform (Automated Breast Ultrasound). The open platform technology of Invenia ABUS 2.0 allows third-party AI solutions to be integrated. The FDA has authorised the product as a cancer-detecting supplemental breast screening technique..

Browse the full “Automated Breast Ultrasound Systems Market By Product (Automated Breast Ultrasound System, Automated Breast Volume Scanner), By Application (Screening, Pre-operative Evaluation), End User (Hospitals, Diagnostic centers, Ambulatory Surgery Centers), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/automated-breast-ultrasound-systems-market

Global Automated Breast Ultrasound Systems market is segmented as follows:

By Product

• Automated Breast Ultrasound System
• Auromated Breast Volume Scanner

Application

• Screening
• Pre-operative Evaluation

End User

• Hospitals
• Diagonostic centers
• Ambulatory Surgery Centers

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com